Literature DB >> 7762708

The impact of the 1987 federal regulations on the use of psychotropic drugs in Minnesota nursing homes.

J Garrard1, V Chen, B Dowd.   

Abstract

OBJECTIVES: The purpose of this study was to examine prevalence rates of psychotropic drug use by elderly nursing home residents 3 years before and 1 year after implementation of the 1987 Omnibus Budget Reconciliation Act drug regulations throughout the United States on October 1, 1990.
METHODS: A cohort study was conducted of elderly nursing home residents, for each of 4 study years (approximately 33,000 residents per year), of all nursing homes (n = 372) in Minnesota certified by Medicare and Medicaid. Data included (1) health status assessment and psychotropic drug use; (2) nursing home and care characteristics; and (3) county geographic and population characteristics.
RESULTS: Annual rates of antipsychotic drug use declined by one third over the 4-year period (23%, 22%, 19%, and 15% from 3 years before enforcement of the regulations to 1 year afterward). All differences were statistically significant. Antianxiety use rates were 11%, 12%, 12%, and 12%, respectively, and antidepressant use rates were 14%, 15%, 16%, 16%, respectively, for the 4 years. The latter two classes of drugs were not affected directly by the regulations.
CONCLUSIONS: Declines in the rates of antipsychotic drug use appear to be associated with anticipation of the regulations the year before and as the result of the regulations the year after the October 1990 implementation. A hypothesized medication shift to benzodiazepine drugs was not observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762708      PMCID: PMC1615514          DOI: 10.2105/ajph.85.6.771

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes.

Authors:  B W Rovner; B A Edelman; M P Cox; Y Shmuely
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

2.  Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations.

Authors:  J Garrard; L Makris; T Dunham; L L Heston; S Cooper; E R Ratner; D Zelterman; R L Kane
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

3.  Psychoactive medication use in intermediate-care facility residents.

Authors:  M Beers; J Avorn; S B Soumerai; D E Everitt; D S Sherman; S Salem
Journal:  JAMA       Date:  1988-11-25       Impact factor: 56.272

4.  Psychotropic drug prescriptions for nursing home residents.

Authors:  B J Burns; D B Kamerow
Journal:  J Fam Pract       Date:  1988-02       Impact factor: 0.493

5.  Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study.

Authors:  J Avorn; P Dreyer; K Connelly; S B Soumerai
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

6.  Prescribing of psychotropics in elderly nursing home patients.

Authors:  R S Beardsley; D B Larson; B J Burns; J W Thompson; D B Kamerow
Journal:  J Am Geriatr Soc       Date:  1989-04       Impact factor: 5.562

7.  Psychotropic drug practice in nursing homes.

Authors:  J A Buck
Journal:  J Am Geriatr Soc       Date:  1988-05       Impact factor: 5.562

8.  Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations.

Authors:  R I Shorr; R L Fought; W A Ray
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

9.  Longitudinal study of psychotropic drug use by elderly nursing home residents.

Authors:  J Garrard; T Dunham; L Makris; S Cooper; L L Heston; E R Ratner; D Zelterman; R L Kane
Journal:  J Gerontol       Date:  1992-11

10.  A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.

Authors:  W A Ray; C F Federspiel; W Schaffner
Journal:  Am J Public Health       Date:  1980-05       Impact factor: 9.308

  10 in total
  9 in total

Review 1.  The drive for quality care in US nursing homes in the era of the prospective payment system.

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 2.  Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Pharmacy interventions on prescribing in nursing homes: from evidence to practice.

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 4.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

5.  State regulatory enforcement and nursing home termination from the medicare and medicaid programs.

Authors:  Yue Li; Charlene Harrington; William D Spector; Dana B Mukamel
Journal:  Health Serv Res       Date:  2010-09-01       Impact factor: 3.402

6.  Optimising drug utilisation in long term care.

Authors:  Kate L Lapane; Carmel M Hughes
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Does organisational culture influence prescribing in care homes for older people? A new direction for research.

Authors:  Carmel M Hughes; Kate Lapane; Margaret C Watson; Huw T O Davies
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study.

Authors:  Zhanlian Feng; John P Hirdes; Trevor F Smith; Harriet Finne-Soveri; Iris Chi; Jean-Noel Du Pasquier; Ruedi Gilgen; Naoki Ikegami; Vincent Mor
Journal:  Int J Geriatr Psychiatry       Date:  2009-10       Impact factor: 3.485

9.  Assessment of a United States pharmaceutical care model for nursing homes in the United Kingdom.

Authors:  Susan M Patterson; Carmel M Hughes; Kate L Lapane
Journal:  Pharm World Sci       Date:  2007-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.